---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-026140"
form_type: "8-K"
ticker: "ARKO"
cik: "0001823794"
company_name: "ARKO Corp."
filed_at: "2023-06-02T23:59:59+00:00"
generated_at: "2026-06-14T08:29:10.572035+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# ARKO non-compliant with Nasdaq audit committee rule after director resignation; cure period until Nov 1, 2023

## Summary
- Director Starlette Johnson resigned from board and audit committee effective May 5, 2023.
- Audit Committee now has fewer than three members, violating Nasdaq Listing Rule 5605(c)(2).
- Nasdaq confirmed non-compliance on June 2, 2023; cure period expires November 1, 2023.
- Company expects to cure before deadline and actively seeking audit committee replacement.

## SEC filing metadata
- accession: 0000950170-23-026140
- form_type: 8-K
- ticker: ARKO
- cik: 0001823794
- company_name: ARKO Corp.
- filed_at: 2023-06-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1823794/000095017023026140/0000950170-23-026140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1823794/000095017023026140/arko-20230531.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-026140
- JSON: https://secwatch.observer/filing/0000950170-23-026140.json
- Plain text: https://secwatch.observer/filing/0000950170-23-026140.txt

## Key facts
- Listing & Compliance Notices
  ARKO Corp. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2), 5605(c)(4)(B)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: audit committee
  - Rules: 5605(c)(2), 5605(c)(4)(B)
  source text: June 2, 2023, the Company received a notification from Nasdaq confirming the foregoing and that, as permitted by Nasdaq Listing Rule 5605(c)(4)(B), the Company has until November 1, 2023 to cure this non-compliance. The Company expects to cure this non-compliance prior to November 1, 2023 and has an active search underway to fill the vacancy on the Audit Committee. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ARKO Corp. Date: June 2, 2023 By: /s/
  evidence_url: https://www.sec.gov/Archives/edgar/data/1823794/000095017023026140/0000950170-23-026140-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.